![]() Yourgene Health Yourgene Health (formerly known as Premaitha Health) is an integrated technologies and services company specializing in genomic medicine. | ![]() Fulgent Genetics Fulgent Therapeutics is a technology company offering large-scale COVID-19 testing services, molecular diagnostic testing services, and comprehensive genetic testing. | EUROIMMUN EUROIMMUN is a company developing test systems and automation solutions for medical laboratory diagnostics. | Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer. | ||
Founding Date | Founding Date 2013 | Founding Date 2004 | Founding Date 2011 | Founding Date 1987 | Founding Date 2008 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Manchester, GB HQ Port Coquitlam, CA Paris, FR Düsseldorf, DE Singapore, SG Taipei, TW Miami Beach, US | Locations Marshfield, US HQ | Locations Temple City, US HQ Houston, US | Locations Lübeck, DE HQ San José, CR Bussy Saint Martin, FR Bernstadt Auf Dem Eigen, DE Herrnhut, DE Pegnitz, DE see more | Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US |
Employees | Employees 164 | Employees 1751% decrease | Employees 1,01257% increase | Employees 7922% increase | Employees 8154% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 606.8 m | Valuation ($) N/A | Valuation ($) 2.6 b |
Financial | |||||
Revenue (est.) | Revenue (est.) £37.6m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $322.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $517.1m (FY, 2025) |
Cost of goods | Cost of goods £16.2m (FY, 2022) | Cost of goods N/A | Cost of goods $191.8m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit £21.4m (FY, 2022) | Gross profit N/A | Gross profit $130.9m (FY, 2025) | Gross profit N/A | Gross profit $362.5m (FY, 2025) |
Net income | Net income (£1.9m) (FY, 2022) | Net income N/A | Net income ($61.6m) (FY, 2025) | Net income N/A | Net income $66.4m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 34.9m | Total funding raised N/A | Total funding raised $ 116.3m |

PreventionGenetics is a company operating as a clinical DNA testing laboratory.
View company
Fulgent Therapeutics is a technology company offering large-scale COVID-19 testing services, molecular diagnostic testing services, and comprehensive genetic testing.
View companyEUROIMMUN is a company developing test systems and automation solutions for medical laboratory diagnostics.
View companyVeracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
View company